| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.69 | 0.01 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |